Literature DB >> 10600112

Reduction of furin-nicked Pseudomonas exotoxin A: an unfolding story.

M L McKee1, D J FitzGerald.   

Abstract

Upon entering mammalian cells, Pseudomonas exotoxin A (PE) is proteolytically processed by furin to produce an N-terminal fragment of 28 kDa and a C-terminal fragment of 37 kDa. Cleavage is followed by the reduction of a key disulfide bond (cysteines 265-287). This combination of proteolysis and reduction releases the 37 kDa C-terminal fragment, which then translocates to the cytosol where it ADP-ribosylates elongation factor 2 and inhibits protein synthesis. To investigate toxin reduction, furin-nicked PE or a hypercleavable mutant, PEW281A, was subjected to various treatments and then analyzed for fragment production. Reduction was evident only when unfolding conditions and a reducing agent were applied. Thermal unfolding of PE, as evidenced by changes in alpha-helical content and increased sensitivity to trypsin, rendered nicked toxin susceptible to protein disulfide isomerase- (PDI-) mediated reduction. When subcellular fractions from toxin-sensitive cells were incubated with nicked PE, toxin unfolding and reducing activities were present in the membrane fraction but not the soluble fraction. These data indicate that PE reduction is a two-step process: unfolding that allows access to the Cys265-287 disulfide bond, followed by reduction of the sulfur-sulfur bond by PDI or a PDI-like enzyme. With regard to cellular processing, we propose that the toxin's three-dimensional structure retains a "closed" conformation that restricts solvent access to the Cys265-287 disulfide bond until after a cell-mediated unfolding event.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10600112     DOI: 10.1021/bi991308+

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.321


  34 in total

Review 1.  Endoplasmic reticulum-dependent redox reactions control endoplasmic reticulum-associated degradation and pathogen entry.

Authors:  Christopher P Walczak; Kaleena M Bernardi; Billy Tsai
Journal:  Antioxid Redox Signal       Date:  2012-01-30       Impact factor: 8.401

2.  Detection of toxin translocation into the host cytosol by surface plasmon resonance.

Authors:  Michael Taylor; Tuhina Banerjee; Neyda VanBennekom; Ken Teter
Journal:  J Vis Exp       Date:  2012-01-03       Impact factor: 1.355

3.  A PDI family network acts distinctly and coordinately with ERp29 to facilitate polyomavirus infection.

Authors:  Christopher P Walczak; Billy Tsai
Journal:  J Virol       Date:  2010-12-15       Impact factor: 5.103

Review 4.  Immunotoxins for targeted cancer therapy.

Authors:  Robert J Kreitman
Journal:  AAPS J       Date:  2006-08-18       Impact factor: 4.009

Review 5.  Novel bacterial ADP-ribosylating toxins: structure and function.

Authors:  Nathan C Simon; Klaus Aktories; Joseph T Barbieri
Journal:  Nat Rev Microbiol       Date:  2014-07-14       Impact factor: 60.633

Review 6.  Immunoconjugates in the management of hairy cell leukemia.

Authors:  Robert J Kreitman; Ira Pastan
Journal:  Best Pract Res Clin Haematol       Date:  2015-10-09       Impact factor: 3.020

7.  Two highly conserved cysteine residues in HPV16 L2 form an intramolecular disulfide bond and are critical for infectivity in human keratinocytes.

Authors:  Samuel K Campos; Michelle A Ozbun
Journal:  PLoS One       Date:  2009-02-13       Impact factor: 3.240

Review 8.  Immunotoxins for leukemia.

Authors:  Alan S Wayne; David J Fitzgerald; Robert J Kreitman; Ira Pastan
Journal:  Blood       Date:  2014-02-27       Impact factor: 22.113

9.  Neutralizing monoclonal antibodies against ricin's enzymatic subunit interfere with protein disulfide isomerase-mediated reduction of ricin holotoxin in vitro.

Authors:  Joanne M O'Hara; Nicholas J Mantis
Journal:  J Immunol Methods       Date:  2013-06-15       Impact factor: 2.303

10.  Protein disulphide-isomerase reduces ricin to its A and B chains in the endoplasmic reticulum.

Authors:  Robert A Spooner; Peter D Watson; Catherine J Marsden; Daniel C Smith; Katherine A H Moore; Jonathon P Cook; J Michael Lord; Lynne M Roberts
Journal:  Biochem J       Date:  2004-10-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.